DOES SYSTEMIC ANTICANCER GEMCITABINE COMPROMISE ORAL SOFT TISSUE WOUND HEALING?
| dc.contributor.author | Alyaa I. Naser.1 Rayan S. Hamed.1 Ghada A. Taqa.2 | |
| dc.date.accessioned | 2026-04-21T07:42:52Z | |
| dc.date.issued | 2022 | |
| dc.identifier.citation | .researchgate.net/publication/370082940_Does_systemic_anticancer_gemcitabine_compromise_oral_soft_tissue_wound_healing | |
| dc.identifier.issn | 0719-2460 | |
| dc.identifier.uri | https://drcentrallibrary.uomosul.edu.iq/handle/123456789/4833 | |
| dc.language.iso | en | |
| dc.publisher | جامعة الموصل /University of Mosul | |
| dc.relation.ispartofseries | 30R | |
| dc.subject | Mouth mucosa | |
| dc.subject | Antineoplastic agents | |
| dc.subject | Gemcitabine | |
| dc.subject | Wound healing | |
| dc.subject | Inflammation | |
| dc.subject | Apoptosis. | |
| dc.title | DOES SYSTEMIC ANTICANCER GEMCITABINE COMPROMISE ORAL SOFT TISSUE WOUND HEALING? | |
| dc.type | Other |